Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Perkins Adds 19 CMC Shares via Dividend Equivalents Nov 11

Director Tandra C. Perkins of Commercial Metals Company filed a Form 4 on November 12, 2026, reporting the acquisition of 19 shares of common stock on November 11, 2026, through dividend equivalents deferred into restricted stock units.

Aditi Sarkar | 12 November 2026

McPherson Acquires 42 CMC Shares via Dividend Equivalents

Director John R. McPherson filed a Form 4 with the SEC on November 12, 2026, reporting the acquisition of 42 shares of Commercial Metals Company common stock on November 11, 2026, through dividend equivalents deferred into restricted stock units.

Aditi Sarkar | 12 November 2026

Hickton Acquires 4 CMC Shares via Dividend Equivalents

Director Dawne S. Hickton filed a Form 4 with the SEC on November 12, 2026, reporting the acquisition of 4 shares of Commercial Metals Company common stock on November 11, 2026, through dividend equivalents deferred into restricted stock units.

Manish Choudhary | 12 November 2026

Next Technology Names Chan Phang Chuen as New CTO

Next Technology Holding Inc. filed a Form 8-K on November 12, 2026, reporting the resignation of Dr. Hongliang Liu as Chief Technical Officer and the appointment of Mr. Chan Phang Chuen to that role, both effective November 9, 2026.

Shwetambri Chauhan | 12 November 2026

Chang-Wei Chiu Named Chair of Aurelion Nominating Committee

Aurelion Inc. filed a Form 6-K with the SEC on November 12, 2026, reporting a change in the composition of its Nominating and Corporate Governance Committee effective November 11, 2026.

Vinay Lochav | 12 November 2026

Jonathan Banner Sells 750 MCD Shares at $279

Jonathan Banner, EVP and Chief Impact Officer at McDonald's Corporation, filed a Form 4 on November 12, 2026, disclosing the sale of 750 shares of McDonald's common stock on November 11, 2026.

Shwetambri Chauhan | 12 November 2026

Applied Aerospace & Defense (NYSE:AADX) Beats Q3 Estimates With EPS of USD 0.18 on Record Revenue of USD 182.1 Million

Management described record revenue and adjusted EBITDA, with sequential growth in each of the first three quarters. It said each of its three market areas delivered double digit reported revenue growth.Net Incomewas USD 30.6 million, or USD 0.18 per diluted share, against USD 2.7 …

Nitish Kishor | 12 November 2026

Arbutus Biopharma (NASDAQ:ABUS) Posts Q3 EPS of USD 0.30 Following Moderna Settlement Payment

Research and development expenses decreased USD 3.2 million in the quarter and USD 10.6 million for the nine months compared with the same periods of 2025. Accrued restructuring costs were USD 0.1 million at September 30.

Nitish Kishor | 12 November 2026

ABVC BioPharma, Inc. (NASDAQ:ABVC) Narrows Q3 Net Loss to USD 1.39 Million With No Revenue

For the nine months ended September 30, 2026, net loss was USD 3,890,550 compared with USD 5,360,496 a year earlier, a decrease of USD 1,469,946, or 37%. Revenue was also zero for the nine month periods in both years.

Nitish Kishor | 12 November 2026

ACCESS Newswire (NYSE American:ACCS) Q3 EPS of USD 0.14 Beats Estimate; Revenue Trails

Adjusted EBITDA was USD 829,000, or 15% of revenue, and cash flows from operations were USD 469,000. Gross margin was USD 4.2 million, or 75% of revenue, compared with 73% in the second quarter and 75% a year earlier.

Nitish Kishor | 12 November 2026
Support

Hi! How can we help you today?

Loading…